Canadian Peptides for Research: A Preclinical Profile of GHK-Cu
A preclinical science overview of GHK-Cu for researchers sourcing verified canadian peptides. HPLC tested, COA on every order. Ships Canada-wide.
GHK-Cu: Compound Overview
GHK-Cu is a tripeptide composed of glycine, L-histidine, and L-lysine, with a high-affinity binding site for copper(II) ions. It occurs endogenously in human plasma, saliva, and urine, with plasma concentrations that appear to decline with age — a pattern that has generated considerable interest in biogerontology research.
In its synthesized form, GHK-Cu is produced as a lyophilized research compound. It has been studied in rodent models, cell culture systems, and gene expression platforms across a range of research areas including skin biology, wound healing, anti-fibrotic signaling, and nervous system function.
Mechanism of Action in Preclinical Models
Pickart and Margolina (2018) conducted a comprehensive review of GHK-Cu's activity, synthesizing data from multiple programs. Their analysis identified GHK-Cu as modulating the expression of over 4,000 genes in human cell lines, with observed effects on pathways governing collagen and glycosaminoglycan synthesis, anti-inflammatory signaling, and antioxidant gene upregulation.
What to Look for in a Research Peptide Supplier
- HPLC Purity and Identity Testing: Should confirm both the identity of the compound and its purity via UV peak integration.
- Endotoxin Screening: LAL endotoxin testing should be documented per batch.
- Batch-Specific Certificate of Analysis: Each lot should carry an independently issued COA.
- Third-Party Canadian Laboratory Verification: Domestic third-party certification ensures consistent, auditable testing.
- 1.Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
- 2.Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways. Biomed Res Int. 2015;2015:648108.